ASX - By Stock
|
ACW |
Re:
Ann: First patient treated in ACW XanaMIA ph 2b Alzheimers trial
|
|
DavieJones
|
26 |
9.5K |
4 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
26
|
9.5K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Reject Name Change Resolution
|
|
DavieJones
|
43 |
13K |
13 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
43
|
13K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
DavieJones
|
98 |
30K |
37 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
98
|
30K
|
37
|
|
ASX - By Stock
|
IBX |
Re:
Total Confusion
|
|
DavieJones
|
34 |
10K |
2 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
34
|
10K
|
2
|
|
ASX - By Stock
|
PER |
Re:
News: ANP Antisense Therapeutics Submits Clinical Trial Application For Atl1102 Phase Iib Dmd Trial...
|
|
DavieJones
|
29 |
10K |
19 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
29
|
10K
|
19
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
DavieJones
|
3.5K |
1.0M |
13 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
DavieJones
|
228 |
87K |
11 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
228
|
87K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
DavieJones
|
228 |
87K |
5 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
228
|
87K
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
DavieJones
|
3.5K |
1.0M |
9 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
9
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Says US DOD Naval Medical Research Center Requests Meeting With FDA On Two Phase...
|
|
DavieJones
|
50 |
20K |
3 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
50
|
20K
|
3
|
|
ASX - By Stock
|
IMC |
Upcoming trial of Travelan by the US & UK military
|
|
DavieJones
|
6 |
2.0K |
3 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
6
|
2.0K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
IMM-124e reduces LPS
|
|
DavieJones
|
13 |
4.3K |
5 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
13
|
4.3K
|
5
|
|
ASX - By Stock
|
IMC |
Pediatric NAFLD trial has been completed
|
|
DavieJones
|
2 |
1.0K |
3 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
2
|
1.0K
|
3
|
|
ASX - By Stock
|
IMC |
WRAIR year in review 2019
|
|
DavieJones
|
20 |
5.5K |
2 |
04/05/20 |
04/05/20 |
ASX - By Stock
|
20
|
5.5K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
DavieJones
|
378 |
132K |
2 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
378
|
132K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
News of Cavatak continues!
|
|
DavieJones
|
8 |
13K |
2 |
06/11/19 |
06/11/19 |
ASX - By Stock
|
8
|
13K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron filed XBRL data with the SEC
|
|
DavieJones
|
9 |
3.4K |
8 |
30/10/19 |
30/10/19 |
ASX - By Stock
|
9
|
3.4K
|
8
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Response to ASX Aware Query
|
|
DavieJones
|
7 |
3.2K |
2 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
7
|
3.2K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: US Defense Reports Immuron Travelan Targets Cholera
|
|
DavieJones
|
37 |
13K |
15 |
12/09/19 |
12/09/19 |
ASX - By Stock
|
37
|
13K
|
15
|
|
ASX - By Stock
|
IMC |
Travelan vs Probiotics
|
|
DavieJones
|
0 |
426 |
5 |
05/09/19 |
05/09/19 |
ASX - By Stock
|
0
|
426
|
5
|
|
ASX - By Stock
|
IMC |
C.Diff superbugs
|
|
DavieJones
|
0 |
2.8K |
6 |
19/08/19 |
19/08/19 |
ASX - By Stock
|
0
|
2.8K
|
6
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL Parkinsons trial 2 year data analysis shows success
|
|
DavieJones
|
116 |
44K |
6 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
116
|
44K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
ASCO Conference
|
|
DavieJones
|
28 |
11K |
10 |
04/06/19 |
04/06/19 |
ASX - By Stock
|
28
|
11K
|
10
|
|
ASX - By Stock
|
1AI |
Re:
Ann: CEO Presentation to the 2018 Annual General Meeting
|
|
DavieJones
|
145 |
56K |
10 |
16/01/19 |
16/01/19 |
ASX - By Stock
|
145
|
56K
|
10
|
|
ASX - By Stock
|
IMC |
Re:
Travelan Amazon Page has Been Updated WIth Great Info! (Credit AWIldAna)
|
|
DavieJones
|
6 |
1.9K |
3 |
11/01/19 |
11/01/19 |
ASX - By Stock
|
6
|
1.9K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Nearly a Week of Trading: No Sanyal Presentation
|
|
DavieJones
|
19 |
3.6K |
6 |
15/11/18 |
15/11/18 |
ASX - By Stock
|
19
|
3.6K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
what is merck doing with cavatac
|
|
DavieJones
|
5 |
5.5K |
0 |
23/10/18 |
23/10/18 |
ASX - By Stock
|
5
|
5.5K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
what is merck doing with cavatac
|
|
DavieJones
|
5 |
5.5K |
1 |
19/10/18 |
19/10/18 |
ASX - By Stock
|
5
|
5.5K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
IMO News Is Near
|
|
DavieJones
|
34 |
8.4K |
1 |
25/09/18 |
25/09/18 |
ASX - By Stock
|
34
|
8.4K
|
1
|
|
ASX - By Stock
|
VLA |
Re:
Something afoot ?
|
|
DavieJones
|
22 |
11K |
14 |
18/05/18 |
18/05/18 |
ASX - By Stock
|
22
|
11K
|
14
|
|
ASX - By Stock
|
VLA |
Article in nature.com on onvolytic viruses
|
|
DavieJones
|
4 |
3.2K |
7 |
12/05/18 |
12/05/18 |
ASX - By Stock
|
4
|
3.2K
|
7
|
|
ASX - By Stock
|
VLA |
Re:
Something afoot ?
|
|
DavieJones
|
22 |
11K |
6 |
03/05/18 |
03/05/18 |
ASX - By Stock
|
22
|
11K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO to Present at RedChip Global Online Growth Conf
|
|
DavieJones
|
35 |
14K |
1 |
24/04/18 |
24/04/18 |
ASX - By Stock
|
35
|
14K
|
1
|
|
ASX - By Stock
|
VLA |
Re:
Latest clinical trial results
|
|
DavieJones
|
17 |
10K |
2 |
11/04/18 |
11/04/18 |
ASX - By Stock
|
17
|
10K
|
2
|
|
ASX - By Stock
|
VLA |
Latest clinical trial results
|
|
DavieJones
|
17 |
10K |
7 |
11/04/18 |
11/04/18 |
ASX - By Stock
|
17
|
10K
|
7
|
|
ASX - By Stock
|
VLA |
Re:
IDO1/Keytruda combo trial fails in melanoma
|
|
DavieJones
|
16 |
9.0K |
8 |
07/04/18 |
07/04/18 |
ASX - By Stock
|
16
|
9.0K
|
8
|
|
ASX - By Stock
|
VLA |
IDO1/Keytruda combo trial fails in melanoma
|
|
DavieJones
|
16 |
9.0K |
22 |
07/04/18 |
07/04/18 |
ASX - By Stock
|
16
|
9.0K
|
22
|
|
ASX - By Stock
|
VLA |
Re:
63 Million Shares traded since announcement
|
|
DavieJones
|
38 |
16K |
5 |
28/03/18 |
28/03/18 |
ASX - By Stock
|
38
|
16K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Financial News Network Presentation
|
|
DavieJones
|
104 |
39K |
22 |
23/03/18 |
23/03/18 |
ASX - By Stock
|
104
|
39K
|
22
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Ceasing to be a substantial holder from MS
|
|
DavieJones
|
48 |
25K |
15 |
21/03/18 |
21/03/18 |
ASX - By Stock
|
48
|
25K
|
15
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Form 604 - Change in Substantial Shareholding (Grandlodge)
|
|
DavieJones
|
4 |
2.7K |
2 |
20/03/18 |
20/03/18 |
ASX - By Stock
|
4
|
2.7K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Trial Results
|
|
DavieJones
|
47 |
14K |
2 |
24/02/18 |
24/02/18 |
ASX - By Stock
|
47
|
14K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Incredulous
|
|
DavieJones
|
97 |
42K |
25 |
23/02/18 |
23/02/18 |
ASX - By Stock
|
97
|
42K
|
25
|
|
ASX - By Stock
|
IMC |
C.Difficile trial article
|
|
DavieJones
|
7 |
3.1K |
6 |
17/02/18 |
17/02/18 |
ASX - By Stock
|
7
|
3.1K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Fat Fraction
|
|
DavieJones
|
16 |
6.3K |
7 |
13/02/18 |
13/02/18 |
ASX - By Stock
|
16
|
6.3K
|
7
|
|
ASX - By Stock
|
VLA |
Re:
Quiet time?
|
|
DavieJones
|
44 |
20K |
1 |
30/01/18 |
30/01/18 |
ASX - By Stock
|
44
|
20K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Current Nash Players
|
|
DavieJones
|
2 |
1.3K |
6 |
22/01/18 |
22/01/18 |
ASX - By Stock
|
2
|
1.3K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
Ann: $29.6m Equity Placement to Lepu Medical Group of China
|
|
DavieJones
|
80 |
33K |
21 |
10/01/18 |
10/01/18 |
ASX - By Stock
|
80
|
33K
|
21
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Trading Halt
|
|
DavieJones
|
78 |
33K |
2 |
07/01/18 |
07/01/18 |
ASX - By Stock
|
78
|
33K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Trading Halt
|
|
DavieJones
|
78 |
33K |
5 |
04/01/18 |
04/01/18 |
ASX - By Stock
|
78
|
33K
|
5
|
|